SIC 8734 – Testing Laboratories
| Valuation | |
|---|---|
| Market Cap ($M) | 18,255.62 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 877.00 |
| Book Value / Share | 4.52 |
| Price / Book | n/a |
| NCAV ($M) | -3,026.00 |
| NCAV / Share | -15.58 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.12 |
| Return on Assets (ROA) | 0.08 |
| Return on Equity (ROE) | 0.84 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.11 |
| Current Ratio | 1.13 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2,846.00 |
| Assets | 6,749.00 |
| Liabilities | 5,872.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 6,794.00 |
| Operating Income | 922.00 |
| Net Income | 581.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 1,224.00 |
| Cash from Investing | -393.00 |
| Cash from Financing | -1,194.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| OHCS – Optimus Healthcare Services, Inc. | ORYZF – Oryzon Genomics S.A. |
| PXMTF – PHAXIAM Therapeutics S.A. | TCHBF – Tecan Group AG |
| USRM – U.S. Stem Cell, Inc. |
Financial data and stock pages provided by
Fintel.io